Yield10 Bioscience Inc [NASDAQ: YTEN] closed the trading session at $0.31. The company report on April 1, 2024 at 4:01 PM that Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results. -Granted global commercial license to Vision Bioenergy for Camelina addressing the biofuel
Yield10 Bioscience Inc [NASDAQ: YTEN] gained 78.85% on the last trading session, reaching $0.43 price per share at the time. The company report on March 21, 2024 at 8:29 AM that USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the
Yield10 Bioscience Inc [NASDAQ: YTEN] gained 52.57% or 0.12 points to close at $0.35 with a heavy trading volume of 128038274 shares. The company report on January 8, 2024 at 8:31 AM that Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina
© 2024, Powered by Smart TechOne
